08/20/2025
3:38 PM | Bode John B (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2025
4:24 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/26/2025
3:25 PM | Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2025
4:28 PM | Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
8:37 PM | Anderson Thomas (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
8:38 PM | Bode John B (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
8:38 PM | Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
8:39 PM | FAVORITO TAMARA A (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
8:39 PM | Calder Douglas W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
8:40 PM | DIXON WENDY L (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
8:41 PM | Shih Alvin (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ZVRA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/24/2025
4:21 PM | Mangless Daniel John (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form PRRN14A | |
04/23/2025
4:29 PM | Mangless Daniel John (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form DFAN14A | |
04/21/2025
6:02 AM | ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form DEFC14A | |
04/21/2025
6:17 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form DEFA14A | |
04/10/2025
4:14 PM | Mangless Daniel John (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form PREC14A | |
04/07/2025
3:31 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form DEFA14A | |
04/07/2025
7:04 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
7:05 PM | Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
4:28 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form DEFA14A | |
03/27/2025
7:30 PM | Quartel Adrian W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2025
7:31 PM | Quartel Adrian W (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
5:06 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2025
4:23 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
6:38 AM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:54 PM | McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:55 PM | Clifton R. LaDuane (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:55 PM | Schafer Joshua (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:57 PM | Sangiovanni Timothy J. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
3:38 PM | McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2025
8:32 AM | Adage Capital Management, L.P. (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/10/2025
4:37 PM | McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/03/2025
4:19 PM | McFarlane Neil F. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
4:20 PM | Clifton R. LaDuane (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
4:22 PM | Schafer Joshua (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
4:23 PM | Thompson Rahsaan (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
4:24 PM | Sangiovanni Timothy J. (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
4:28 PM | ZEVRA THERAPEUTICS, INC. (Filer)
Zevra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:53 PM | Nantahala Capital Management, LLC (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
11/04/2024
1:15 PM | VANGUARD GROUP INC (Filed by)
ZEVRA THERAPEUTICS, INC. (Subject)
Zevra Therapeutics (Subject)
| Form SC 13G/A | |
What Are Some Strategies to Help Lower RMD Taxes? (Ad) Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg.
SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest. Click here to see the six strategies and get your free advisor matches today. |
10/16/2024
3:46 PM | Watton Corey Michael (Reporting)
ZEVRA THERAPEUTICS, INC. (Issuer)
Zevra Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
MarketBeat All Access